News Torrent Pharmaceuticals Limited

Equities

TORNTPHARM

INE685A01028

Market Closed - Bombay S.E. Other stock markets 06:00:49 2024-04-25 am EDT			5-day change	1st Jan Change
2,692 ^INR	+0.28%		+6.14%	+16.81%

Apr. 08	Torrent Pharmaceuticals Limited Receives an Order Passed Under Section 73 of the Goods and Service Act, 2017, Imposing A Penalty of INR 388,809.60	CI
Apr. 01	Torrent Pharmaceuticals Limited Announces Change in Directorate , Effective 31 March 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Torrent Pharmaceuticals Limited Receives an Order Passed Under Section 73 of the Goods and Service Act, 2017, Imposing A Penalty of INR 388,809.60	Apr. 08	CI
Torrent Pharmaceuticals Limited Announces Change in Directorate , Effective 31 March 2024	Apr. 01	CI
Torrent Pharmaceuticals Limited Announces Superannuation of Ashok Modi as Executive Director	Feb. 29	CI
Ex-dividend day for interim dividend	Feb. 11	FA
Nomura Adjusts Torrent Pharmaceuticals' Price Target to INR2,975 From INR2,156, Keeps at Buy	Feb. 08	MT
Supernus Wins Infringement and Validity Case on Trokendi XR against Torrent	Feb. 06	AQ
Supernus Says US District Court Rules Torrent Pharmaceuticals Infringed Patents	Feb. 05	MT
Jefferies Adjusts Torrent Pharmaceuticals' Price Target to INR2,930 From INR2,750, Keeps at Buy	Feb. 05	MT
Torrent Pharmaceuticals Posts Gains in Fiscal Q3 Consolidated Net Profit	Feb. 04	MT
Torrent Pharmaceuticals' Consolidated Profit in Fiscal Q3	Feb. 02	MT
Transcript : Torrent Pharmaceuticals Limited, Q3 2024 Earnings Call, Feb 02, 2024	Feb. 02
India's Torrent Pharma posts higher Q3 profit on strong domestic demand	Feb. 02	RE
Torrent Pharmaceuticals Limited Announces Interim Dividend, Payable on or around 23 February, 2024	Feb. 02	CI
Torrent Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 02	CI
India's Glenmark Life Sciences posts Q3 profit rise; strong orderbook ahead, says CEO	Jan. 23	RE
Torrent Pharmaceuticals Forms New Wholly-Owned Arm in Colombia	Jan. 04	MT
Torrent Pharmaceuticals' Oral Oncology Plant Gets Fives Observations from US FDA	Dec. 11	MT
Zydus Lifesciences Limited and Torrent Pharmaceuticals Limited Enter into Licensing and Supply Agreement to Co-Market, Saroglitazar Mg	Nov. 10	CI
Nomura Adjusts Torrent Pharmaceuticals Price Target to INR2,156 From INR2,199, Keeps at Buy	23-10-25	MT
Torrent Pharmaceuticals' Consolidated Profit Climbs in Fiscal Q2; EPS, Revenue Meet Estimates	23-10-24	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Torrent Pharmaceuticals Limited

Equities

TORNTPHARM

INE685A01028

Summary

Filters